Search
Bloomage BioTechnology's proprietary chondroitin sodium raw material, produced through a fermentation process, has triumphantly completed the registration process with the National Medical Products Administration. This achievement positions Bloomage BioTechnology as the pioneering domestic enterprise to secure compliant registration for this type of raw material. Suitable for incorporation in both Class II and Class III medical devices, this raw material is poised to serve as a cornerstone for the production of high-end medical devices in the future. Building on this success, Bloomage BioTechnology aims to delve further into the development of chondroitin sulfate raw materials, leveraging synthetic biology technology, and to expand its reach into ophthalmology, orthopedics, and medical aesthetics.
-
C114 Communication Network -
Communication Home
